The present invention relates generally to the field of devices for the delivery of medications, and more particularly to a system and device for managing and monitoring the use of a medication delivery device.
There is a growing need for medication delivery devices, such as but not limited to auto injectors, jet injectors, syringes, oral inhalers, transdermal and other topical absorption mechanisms, oral, topical, or other spray, or the like, for use by persons with medical conditions that may require real-time management and monitoring. Rescue medication is one category of medications that are provided by a medication delivery device. The need for rescue medication and the use of medication delivery devices such as auto-injectors for rescue medication is also increasing. For people with those needs, carrying a medication delivery device represents a daily routine that impacts their normal life. Specifically, in the case of teens that require rescue medication it is challenging for parents to be sure their child is safe while helping to build their children's independence.
In general there are several issues that need to be addressed for people who carry medication delivery devices with rescue medication: lost or forgotten medication delivery device; expired medication; rescue medication that has been exposed to temperatures and other environmental factors outside predetermined ranges; reliable integration with the technology of new and existing support groups; bystander notifications in case of medical emergency; user's and user's support groups (such as family) assurance and peace of mind; and supporting and building vigilance behaviors and attitudes. What is needed is a comprehensive system for managing and monitoring the use of medication delivery devices.
With parenthetical reference to the corresponding parts, portions or surfaces of the disclosed embodiment, merely for the purposes of illustration and not by way of limitation, the present invention meets the above described need by providing a case (8) for use with a medication delivery device (13), a medication delivery device (13) with an integrated electronic control system, and a medication delivery device management system. The case (8) for use with a medication delivery device (13) includes a housing (10) having an opening (16) bordering a cavity (58) defined therein. The cavity (58) is sized to receive the medication delivery device (13). A cover (22) is disposed adjacent to the opening (16) in the housing (10) and is capable of moving between an open position and a closed position where it covers the opening (16) in the housing (10), A sensor (80) for detecting the presence of the medication delivery device (13) is disposed in the housing (10).
An electronic control system (43) is disposed in wireless communication with a gateway device (82) for connecting to a communications network (100). The electronic control system is configured and arranged to provide a signal indicating that the case (8) is in proximity to the gateway device (82).
The case (8) may further comprise an environmental sensor (44) selected from the group consisting of temperature, light, vibration, pressure, motion, pollution and humidity.
The case (8) may further comprise an emergency standby button (46) configured and arranged such that a user holds the button (46) while assessing an emergency situation and in the event that the user releases the button (46) without following a predetermined routine, an alarm signal will automatically be sent to the gateway device (82) to trigger an auditory alarm perceptible to bystanders and to send an alert to one or more support groups. The case (8) may also directly trigger a local visual or audible alarm or the like.
In another aspect, the gateway device (82) is configured and arranged to send a wireless signal to the housing (10) to provide a paging feature. The signal may cause the housing (10) to emit sound or light to provide for locating the case (8).
In another aspect of the invention, the gateway device (82) automatically receives a signal from the electronic control system (43) when the medication delivery device (13) is removed from the case (8) and the gateway device (82) automatically sends a corresponding alert via a communication network (100) to one or more support groups (49).
In another aspect, the corresponding alert includes information regarding the location of the user of the case (8).
In another aspect of the invention, the gateway device (82) automatically receives a communication from the electronic control system (43) when the case (8) is opened and the gateway device (82) automatically sends a corresponding alert via a communication network (100) to one or more support groups (49).
In another aspect of the invention, upon receipt of a signal indicating that the medication delivery device (13) is not present in the case (8), the gateway device (82) sends a polling signal to the user which requires an active response from the user within a predetermined time.
The case (8) may further comprise the gateway device (82) triggering an audible alarm when the user does not respond to the polling signal.
In another aspect of the invention the gateway device (82) sends a signal that triggers an audible alarm on the housing (10) to provide an alert to persons in the vicinity of the case (8).
In another aspect, the medication delivery device (13) further comprises an electronic tag (62) identifying the medication delivery device (13) contained in the case (8).
In another aspect, the cover (22) is sealingly attached to the housing (10) to protect the medication delivery device (13).
In another aspect, the case further comprises means for providing power (70) to the electronic control system (43).
In another aspect, the corresponding alert includes information regarding the location of the user of the case (8).
In another aspect of the invention a medication delivery device (13) includes an electronic control system (43) operatively associated with the medication delivery device (13) and disposed in wireless communication with a gateway device (82) for connecting to a communications network (100). The electronic control system (43) is configured and arranged to provide signal indicating that the medication delivery device (13) is in proximity to the gateway device (82). When the medication delivery device (13) is activated, the electronic control system (43) automatically transmits a signal to the gateway device (82).
The medication delivery device (13) may further comprise an environmental sensor (44) selected from the group consisting of temperature, light, vibration, pressure, motion, pollution and humidity.
The medication delivery device (13) may further comprise an emergency standby button (46) configured and arranged such that a user holds the button (46) while assessing an emergency situation and in the event that the user releases the button (46) without following a predetermined routine, an alarm signal will automatically be sent to the gateway device (82) to trigger an auditory alarm perceptible to bystanders and to send an alert to one or more support groups. The medication delivery device (13) may also directly trigger a local visual or audible alarm or the like on the device (13).
In another aspect, the gateway device (82) is configured and arranged to send a wireless signal to the medication delivery device (13) to provide a paging feature. The signal may include an auditory or visual signal emitted from the medication delivery device (13).
In another aspect, the medication delivery device further comprises means for providing power (70) to the electronic control system (43).
In another aspect of the invention, a medication delivery device management system includes a medication delivery device (13) and an electronic control system (43) operatively associated with the medication delivery device (13). The electronic control system (43) is disposed in wireless communication with a gateway device (82) for connecting with a communications network (100). The electronic control system (43) is configured and arranged to provide a signal to the gateway device (82) indicating that the medication delivery device (13) is in proximity to the gateway device (82). Also, the electronic control system (43) automatically sends a signal to the gateway device (82) when the medication delivery device (13) is activated.
The medication delivery management system may further comprise an environmental sensor (44) selected from the group consisting of temperature, light, vibration, pressure, motion, pollution and humidity.
In another aspect upon receipt of an alert from the electronic control system (43), the gateway device (82) automatically transmits a corresponding alert to one or more support groups (49).
In another aspect, the gateway device (82) is configured and arranged to send a wireless signal to the medication delivery device (13) to provide a paging feature.
In another aspect, wherein upon receipt of a signal indicating that the medication delivery device (13) has been removed from a case (8), the gateway device (82) sends a polling signal to the user which requires an active response from the user within a predetermined time.
In another aspect, the gateway device (82) triggers an audible alarm on one of the case (8) and the medication delivery device (13) when the user does not respond to the polling signal.
In another aspect, the gateway device (82) sends a signal that triggers an audible alarm on the medication delivery device (13) to provide an alert to persons in the vicinity of the medication delivery device (13).
In another aspect, the medication delivery device (13) further comprises an electronic tag (62) identifying the medication delivery device (13).
In another aspect, the system provides a notification when the medication has expired.
In another aspect, the system provides a notification when the environmental sensor (44) registers a reading that is outside a predetermined range.
At the outset, it should be clearly understood that like reference numerals are intended to identify the same structural elements, portions or surfaces consistently throughout the several drawing figures, as such elements, portions or surfaces may be further described or explained by the entire written specification, of which this detailed description is an integral part. Unless otherwise indicated, the drawings are intended to be read (e.g., cross-hatching, arrangement of parts, proportion, debris, etc.) together with the specification, and are to be considered a portion of the entire written description of this invention. As used in the following description, the terms “horizontal”, “vertical”, ‘left”, “right”, “up” and “down”, as well as adjectival and adverbial derivatives thereof, (e.g., “horizontally”, “rightwardly”, “upwardly”, etc.), simply refer to the orientation of the illustrated structure as the particular drawing figure faces the reader. Similarly, the terms “inwardly” and “outwardly” generally refer to the orientation of a surface relative to its axis of elongation, or of rotation, as appropriate.
Referring now to the drawings, and initially to
The housing 10 provides protection for the auto-injector 13 against physical damage due to dropping and provides protection against environmental damage due to ultraviolet radiation or the like. The housing 10 may have an opening 16 at one end 19. The end 19 may be provided with a cover 22 that has a surface 25 that provides a seal against the edges 28 of the housing 10 surrounding the opening 16. The sealed cover 22 offers protection against the entry of moisture and/or dirt into the housing 10. The cover 22 may be attached to the housing by a hinge 23 or may be movable between an open position and a closed position by other means known to those of ordinary skill in the art based on this disclosure.
The outside surface 31 of the housing 10 may be provided with a plurality of openings that provide a path for light emanating from a light source 37 disposed in the housing 10. Also, the openings 34 may provide a path for sound from a sound emitting device 40 disposed in the housing 10. The light and sound emanating from the housing 10 may be controlled by an electronic control system 43 described in greater detail herein. The lights and sounds provide several functions including paging to assist a user in locating a misplaced housing 10. Also, the user may be provided with automatic audible instructions during an emergency situation. And in an emergency situation where the user is incapacitated, the lights and sounds may provide an alert to third party bystanders to provide or summon aid for the user.
The housing 10 may also be provided with an emergency/standby button 46. The user can press and hold the emergency standby button 46 while assessing the situation during a potential emergency event. If the user decides that they are safe they can deactivate the alert and verbal notification by pressing the button 46 a predetermined number of times after releasing it. Or, in the event that they are no longer able to hold the button 46, the electronic control system 43 triggers an alert to one or more support groups 49 of persons having connected devices 52 (
Turning to
When the cover 22 is in the closed position shown in
The case 8 may also be provided with a sensor for detecting the presence of a medication delivery device within the housing 10. For example, switch 80 may be connected to the electronic control system 43 to detect the presence of the rescue medication delivery device. The switch 80 changes state depending on whether the auto-injector 13 is present in the housing 10. Other sensors such as capacitative, optical, or the like may also be used to detect the presence of the medication delivery device 13 within the case 8.
The electronic control system 43 in the housing 10 is configured to wirelessly communicate with a user's device 82 (
The communications network 100 connected to by the gateway device 82 may comprise a large communications network for connecting the gateway device 82 to one or more support groups 49 of connected devices 52. Accordingly, a condition at the housing 10 may be communicated to the local device 82 via short range communications and then a broadcast communication (i.e. group e-mail or group text) may be automatically sent via the communication network 100 to the group 49 that may comprise a private support group of the user. The communication may also be sent to a larger public, network such as first responders.
The electronic control system 43 may also be provided with environmental sensors 44 such as a temperature sensor that may be disposed on the main circuit board 55. The temperature of the environment may adversely affect the medication, and therefore may need to be monitored. Other environmental sensors 44 such as humidity, light (visible, UV, and infrared and other forms of electromagnetic radiation), atmospheric and local pressure, moisture, vibration and other forms of mechanical impact, motion, pollution and other forms of atmospheric contaminants, or the like may also be applicable for certain situations.
Inserting or charging the batteries 70 or providing power from the power source will activate the system electronics, and the user can establish the wireless connection (e.g. BLUETOOTH brand Smart standard) between the case 8 and the gateway device 82. The gateway device 82 may be provided with a software application that controls the communication between the electronic control system 43 and the gateway device 82 and provides a dashboard or other user interface for managing the system. Once the system is up and running, the user may insert a medication delivery device such as an auto-injector 13 into the housing 10. With the auto-injector 13 inserted in the housing 10, the auto-injector engages the sensor causing the state of the switch 80 to change. The electronic control system 43 may provide Information to the user's gateway device (via the wireless connection) confirming that the auto-injector 13 is properly installed in the housing 10. Moving the cover 22 from the open to the closed position engages the cover sensing switch 79 which will generate a signal to the user's device 82 via the wireless connection that the housing 10 is properly sealed. At this point, the system will start monitoring and managing the following features: proximity of the case 8 relative to the device 82; temperature and other environmental sensors 44; expiration date of the rescue medication; emergency use of the rescue medication; access to the support network; and bystander notifications in case of medical emergency.
With regard to proximity monitoring, this function is performed through constant wireless communication (e.g. using the BLUETOOTH brand Smart standard) between the system and the application on the device 82. If the communication is interrupted (due to attenuation of received wireless power signal due to distance), the application on the device 82 will automatically notify the user that the system is out of proximity. The system automatically triggers a notification on the user's mobile device 82 and optionally, to its private support group 49, To provide additional flexibility when the use is in locations considered low-risk, such as home, the user can configure “safety zones” with larger proximity areas based on geolocation or other wireless facilities. The user can then take the necessary action (e.g., return to the location of the case 8) to bring the case 8 back into the communication range. This scenario applies if, for example, the user leaves the case 8 at home or somewhere else.
Proximity monitoring may also be used to find the auto-injector 13 if the user forgets the location of the case 8 (assuming the auto-injector is inside the case 8). On the application on the device 82 the user can access the “find me” or paging feature. Once this feature is enabled, the application on the device 82 will communicate wirelessly with the electronic control system 43 and cause the case 8 to emit an audio tone and visual indicators for the user to easily locate the misplaced auto-injector 13. The application on the mobile device 82 remembers the last known location of the user's device so it can find the monitored enclosure in the house or even across the city. As an alternative, the device 82 may send a signal to an electronic control system 43 that is integrated into the medication delivery device such as the body of the auto-injector 13 itself.
The environmental sensor 44 on the electronic board 55 inside the case 8 monitors the temperature inside the housing 10. If the measured temperature goes outside of the operating range set by the user, the application on the device 82 will inform the user of that event. The sensor will monitor the temperature range (and other environmental data) even if there is no wireless communication between the mobile application and the system. Once connected, the temperature monitoring activity is uploaded to the application on the device 82 and if the data points outside the operating range the user will be notified.
In case of an emergency where the user needs to use the rescue medication, once the cover 22 is open and the auto injector 13 is removed, the system will automatically send an alert in real-time to everyone in the user's private support group 49. Based on the user's preferences, this alert may also be sent to people in the extended and public community support groups that are close to the user. Information about the user's location may be shared with the user's support group so that they can come to the user's aid directly and/or contact emergency services on behalf of the user.
The present invention contemplates that many changes and modifications may be made. Therefore, while the presently-preferred form of the system and device for management of medication delivery devices has been shown and described, and several modifications and alternatives discussed, persons skilled in this art will readily appreciate that various additional changes and modifications may be made without departing from the spirit of the invention, as defined and differentiated by the following claims.
This application is a continuation of PCT International Application PCT/IB2015/001416, filed Jun. 15, 2015, which claims the benefit of U.S. Provisional Application No. 62/012,147, filed Jun. 13, 2014. The entire content of PCT Application No. PCT/IB2015/001416 and U.S. Provisional Application No. 62/012,147 are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
6817986 | Slate et al. | Nov 2004 | B2 |
7534230 | Follman et al. | May 2009 | B2 |
7713229 | Veit et al. | May 2010 | B2 |
7731686 | Edwards et al. | Jun 2010 | B2 |
7749194 | Edwards et al. | Jul 2010 | B2 |
7752085 | Monroe | Jul 2010 | B2 |
7782192 | Jeckelmann et al. | Aug 2010 | B2 |
7871393 | Monroe | Jan 2011 | B2 |
7901383 | Follman et al. | Mar 2011 | B2 |
8044778 | Monroe | Oct 2011 | B2 |
8149111 | Monroe | Apr 2012 | B2 |
8172082 | Edwards et al. | May 2012 | B2 |
8206340 | Arefieg | Jun 2012 | B2 |
8212658 | Monroe | Jul 2012 | B2 |
8361026 | Edwards et al. | Jan 2013 | B2 |
8544645 | Edwards et al. | Oct 2013 | B2 |
8551039 | Veit et al. | Oct 2013 | B2 |
8562558 | Kamath et al. | Oct 2013 | B2 |
8639288 | Friedman | Jan 2014 | B1 |
8672899 | Diller et al. | Mar 2014 | B2 |
8690827 | Edwards et al. | Apr 2014 | B2 |
8808228 | Brister et al. | Aug 2014 | B2 |
8817258 | Whalley et al. | Aug 2014 | B2 |
8882704 | Fago et al. | Nov 2014 | B2 |
8899987 | Edwards et al. | Dec 2014 | B2 |
8920374 | Bokelman et al. | Dec 2014 | B2 |
8922367 | Denny et al. | Dec 2014 | B2 |
8926594 | Edwards et al. | Jan 2015 | B2 |
8932252 | Edwards et al. | Jan 2015 | B2 |
8979799 | Askarinya et al. | Mar 2015 | B1 |
9022980 | Edwards et al. | May 2015 | B2 |
9069333 | Romans | Jun 2015 | B1 |
9125991 | Schabbach et al. | Sep 2015 | B2 |
9138539 | Friedman | Sep 2015 | B1 |
9250111 | Whalley et al. | Feb 2016 | B2 |
9255830 | Whalley et al. | Feb 2016 | B2 |
9295784 | Eggert et al. | Mar 2016 | B2 |
9327077 | Edwards et al. | May 2016 | B2 |
9358334 | Arefieg | Jun 2016 | B2 |
9381294 | Ziegner | Jul 2016 | B2 |
9457147 | Green | Oct 2016 | B2 |
9474869 | Edwards et al. | Oct 2016 | B2 |
9492618 | Day | Nov 2016 | B2 |
9517307 | Blondino et al. | Dec 2016 | B2 |
9539386 | Askarinya et al. | Jan 2017 | B2 |
9539392 | Jennings et al. | Jan 2017 | B2 |
9542826 | Edwards et al. | Jan 2017 | B2 |
9555191 | Edwards et al. | Jan 2017 | B2 |
9566395 | Denny et al. | Feb 2017 | B2 |
9579459 | Jennings et al. | Feb 2017 | B2 |
9597452 | Henderson et al. | Mar 2017 | B2 |
9623188 | Nielsen et al. | Apr 2017 | B2 |
9638564 | Whalley et al. | May 2017 | B2 |
9642968 | Whalley et al. | May 2017 | B2 |
9651482 | Blei et al. | May 2017 | B2 |
9656024 | Eggert et al. | May 2017 | B2 |
9669158 | McLoughlin et al. | Jun 2017 | B2 |
9672328 | Saint et al. | Jun 2017 | B2 |
9682200 | Denny et al. | Jun 2017 | B2 |
9724471 | Edwards et al. | Aug 2017 | B2 |
9737663 | Jennings et al. | Aug 2017 | B2 |
9741139 | Kamath et al. | Aug 2017 | B2 |
9750899 | Ostrander et al. | Sep 2017 | B2 |
9764084 | McLoughlin et al. | Sep 2017 | B2 |
9764101 | McLoughlin et al. | Sep 2017 | B2 |
9775957 | Despa et al. | Oct 2017 | B2 |
9805620 | Edwards et al. | Oct 2017 | B2 |
9814651 | Wengreen et al. | Nov 2017 | B2 |
9836948 | Edwards et al. | Dec 2017 | B2 |
9886556 | Booth et al. | Feb 2018 | B2 |
9911308 | Edwards et al. | Mar 2018 | B2 |
9919106 | Friedman | Mar 2018 | B2 |
9949894 | Puglisi | Apr 2018 | B2 |
9959391 | Saint et al. | May 2018 | B2 |
10022506 | Pribitkin | Jul 2018 | B2 |
10046115 | Bokelman et al. | Aug 2018 | B2 |
10076611 | Edwards et al. | Sep 2018 | B2 |
10092688 | Robinson et al. | Oct 2018 | B2 |
10092706 | Denzer et al. | Oct 2018 | B2 |
10105489 | Edwards et al. | Oct 2018 | B2 |
10143792 | Edwards et al. | Dec 2018 | B2 |
10163311 | Herschkowitz et al. | Dec 2018 | B2 |
10183120 | Sihlanick et al. | Jan 2019 | B2 |
10192464 | Edwards et al. | Jan 2019 | B2 |
10220158 | Blondino et al. | Mar 2019 | B2 |
10229578 | Edwards et al. | Mar 2019 | B2 |
10238806 | Edwards et al. | Mar 2019 | B2 |
10258735 | Edwards et al. | Apr 2019 | B2 |
10258743 | Whalley et al. | Apr 2019 | B2 |
10322239 | Edwards et al. | Jun 2019 | B2 |
10331996 | Schneider et al. | Jun 2019 | B2 |
10332623 | Edwards et al. | Jun 2019 | B2 |
10342924 | Edwards et al. | Jul 2019 | B2 |
10391244 | Schweikert et al. | Aug 2019 | B2 |
10391246 | Henderson et al. | Aug 2019 | B2 |
10398524 | Denny et al. | Sep 2019 | B2 |
10398852 | Taylor et al. | Sep 2019 | B2 |
10413667 | Henderson et al. | Sep 2019 | B2 |
10420623 | Ostrander et al. | Sep 2019 | B2 |
10420895 | Erbstein et al. | Sep 2019 | B2 |
10441714 | Kapas et al. | Oct 2019 | B2 |
20100169111 | Brue | Jul 2010 | A1 |
20110279271 | Monroe | Nov 2011 | A1 |
20120001750 | Monroe | Jan 2012 | A1 |
20130023822 | Fdwards et al. | Jan 2013 | A1 |
20140155827 | Ostrander | Jun 2014 | A1 |
20140221925 | Kondoh | Aug 2014 | A1 |
Number | Date | Country |
---|---|---|
2644547 | Nov 2007 | CA |
2905774 | Nov 2007 | CA |
2825637 | Aug 2012 | CA |
2893413 | Jun 2014 | CA |
2893420 | Jun 2014 | CA |
2896708 | Jul 2014 | CA |
2896746 | Jul 2014 | CA |
2008079340 | Jul 2008 | WO |
2008079340 | Jul 2008 | WO |
2014089083 | Jun 2014 | WO |
2014089086 | Jun 2014 | WO |
2014106056 | Jul 2014 | WO |
2015189700 | Dec 2015 | WO |
Entry |
---|
Documents relating to International App. No. PCT/IB2015/001416 (CIPO Examination Notes for PCT/IB2015/001416 conducted on Nov. 3, 2015). |
Documents relating to International App. No. PCT/IB2015/001416 mailed on Nov. 16, 2015 (Search Report). |
Documents relating to International App. No. PCT/IB2015/001416 mailed Dec. 22, 2016 (International Preliminary Report on Patentability). |
Number | Date | Country | |
---|---|---|---|
20170162033 A1 | Jun 2017 | US |
Number | Date | Country | |
---|---|---|---|
62012147 | Jun 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/IB2015/001416 | Jun 2015 | US |
Child | 15377083 | US |